div-class-title-vitamin-d-deficiency-in-schizophrenia-implications-for-covid-19-infection-div.pdf (224.25 kB)
Vitamin D deficiency in schizophrenia implications for COVID-19 infection
journal contributionposted on 2022-03-16, 12:10 authored by Dylan Viani-Walsh, Sarah Kennedy-Williams, D. Taylor, F. Gaughran, John LallyJohn Lally
Vitamin D deficiency is associated with an increased risk of acute respiratory infection. There is an excess of respiratory infections and deaths in schizophrenia, a condition where vitamin D deficiency is especially prevalent. This potentially offers a modifiable risk factor to reduce the risk for and the severity of respiratory infection in people with schizophrenia, although there is as yet no evidence regarding the risk of COVID-19. In this narrative review, we describe the prevalence of vitamin D deficiency in schizophrenia, report the research examining the relationship between vitamin D levels and COVID-19 and discuss the associations between vitamin D deficiency and respiratory infection, including its immunomodulatory mechanism of action.
CommentsThe original article is available at https://www.cambridge.org/
Published CitationViani-Walsh D, Kennedy-Williams S, Taylor D, Gaughran F, Lally J. Vitamin D deficiency in schizophrenia implications for COVID-19 infection. Ir J Psychol Med. 2020;38(4):278-287.
Publication Date11 September 2020
- Undergraduate Research
PublisherCambridge University Press
- Published Version (Version of Record)